Structure Therapeutics (GPCR) Share-based Compensation (2022 - 2026)
Structure Therapeutics' Share-based Compensation came in at $12.63 million for Q2 2026, up 68.3% from $7.51 million a year earlier and up 8.5% from the prior quarter.
Powered by 
Analysis
Structure Therapeutics (GPCR) Share-based Compensation (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Structure Therapeutics reported Share-based Compensation of $39.84 million, up 57.6% year-over-year; for FY2025, it was $28.99 million, up 54.3% from FY2024.
- Share-based Compensation has increased in each of the last three years, with a three-year compound annual growth rate of 125.9% (FY2022 to FY2025).
- Going back by year, Share-based Compensation was $18.79 million in FY2024 (+129.4%), $8.19 million in FY2023 (+225.8%) and $2.51 million in FY2022.
- The Q2 2026 figure represents the highest quarterly Share-based Compensation in data going back to Q1 2022.
- Year-over-year, Share-based Compensation has increased for 14 consecutive quarters, with growth averaging 103.1% over the last eight quarters.
- Across the past five years, year-over-year growth in Share-based Compensation ran from 8.3% in Q1 2024 to 308.5% in Q1 2023.
- Business Quant data shows GPCR's Share-based Compensation at $11.64 million (Q1 2026), $8.07 million (Q4 2025) and $7.5 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Structure Therapeutics | 7.49 Bn | 7.49 Bn | - | 12.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.63 Mn |
| Mar 31, 2026 | 11.64 Mn |
| Dec 31, 2025 | 8.07 Mn |
| Sep 30, 2025 | 7.50 Mn |
| Jun 30, 2025 | 7.51 Mn |
| Mar 31, 2025 | 5.92 Mn |
| Dec 31, 2024 | 5.83 Mn |
| Sep 30, 2024 | 6.02 Mn |
| Jun 30, 2024 | 4.20 Mn |
| Mar 31, 2024 | 2.74 Mn |
| Dec 31, 2023 | 2.10 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 1.70 Mn |
| Mar 31, 2023 | 2.53 Mn |
| Dec 31, 2022 | 623,000.00 |
| Sep 30, 2022 | 628,000.00 |
| Jun 30, 2022 | 643,000.00 |
| Mar 31, 2022 | 620,000.00 |
API Access
Structure Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GPCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "GPCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GPCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();